XW013H6Introduction of Other New Technology Monoclonal Antibody into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6

  • Billable / Specific Code
ICD-10-PCS XW013H6
CMS Source: FY 2026 ICD-10-PCS dataset. Effective Oct 1, 2025 – Sep 30, 2026.FacebookXLinkedInPrint

XW013H6 is a billable ICD-10-PCS procedure code for Introduction of Other New Technology Monoclonal Antibody into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The root operation Introduction involves putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.

Code Identity

ICD-10-PCS Code
XW013H6
Billable Status
Yes — Valid for Submission
Code Describes
Introduction of Other New Technology Monoclonal Antibody into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6
Parent Code
Short Description
Introduce Monclon Antib in Subcu, Perc, New Tech 6

PCS Table Breakdown

Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.

PositionDesignationValueMeaning
1SectionXNew Technology
2Body SystemWAnatomical Regions
3Operation0Introduction
4BodyPart1Subcutaneous Tissue
5Approach3Percutaneous
6Device/Substance/TechnologyHOther New Technology Monoclonal Antibody
7Qualifier6New Technology Group 6

Code History

Replaces previously assigned code(s):
  • XW013F5 — Introduce New Tech Therap in Subcu, Perc, New Tech 5

Similar Procedure Codes

Questions About XW013H6

Is XW013H6 a billable code?

Yes. XW013H6 is a complete seven-character ICD-10-PCS code, specific enough to report Introduction of Other New Technology Monoclonal Antibody into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6 on inpatient claims from October 1, 2025 through September 30, 2026.

What do the characters in XW013H6 mean?

XW013H6 breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character W is the Body System (Anatomical Regions); the 3rd character 0 is the Operation (Introduction); the 4th character 1 is the BodyPart (Subcutaneous Tissue); the 5th character 3 is the Approach (Percutaneous); the 6th character H is the Device/Substance/Technology (Other New Technology Monoclonal Antibody); the 7th character 6 is the Qualifier (New Technology Group 6).